Literature DB >> 9593271

Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression.

H Sakabe1, N Yahata, T Kimura, Z Z Zeng, H Minamiguchi, H Kaneko, K J Mori, K Ohyashiki, J H Ohyashiki, K Toyama, T Abe, Y Sonoda.   

Abstract

We studied the functional characteristics of subpopulations of cord blood-derived CD34+ cells expressing different levels of CD38 and c-kit antigens, using clonal cell culture and long-term culture with allogeneic bone marrow stromal cells or the MS-5 murine stromal cell line to assay long-term culture-initiating cells (LTC-IC) in each subpopulation. To investigate the capacity for replication, proliferation, and differentiation of each subpopulation of CD34+ cells, we also studied the correlation between LTC-IC and telomerase activity. After 5 weeks of coculture, LTC-IC accounted for one out of 32 CD34+CD38- cells and one out of 33 CD34+c-kit- cells. In contrast, the frequency of LTC-IC was low in their antigen-positive counterparts (one per 84 CD34+CD38+ cells, one per 90 CD34+c-kit(low) cells, and very low among CD34+c-kit(high) cells). It was noteworthy that some LTC-IC derived from CD34+CD38- as well as CD34+c-kit- cells generated colony-forming cells (CFCs) after up to 9 weeks of coculture. Telomerase activity was consistently low in CD34+CD38- and CD34+c-kit- cells compared to CD38+ or c-kit(high or low) cells, suggesting that CD34+CD38- or c-kit- cells are likely to be more quiescent. These results suggest that the CD34+CD38- and CD34+c-kit- cell populations are primitive stem/progenitor cells, and that the telomerase activity of these cells correlates with their proliferative capacity as well as their stage of differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593271     DOI: 10.1038/sj.leu.2401001

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

Review 1.  Mammary epithelial stem cells: our current understanding.

Authors:  G Chepko; G H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion.

Authors:  Katsuhiro Kita; Jong O Lee; Celeste C Finnerty; David N Herndon
Journal:  Stem Cells Int       Date:  2011-04-27       Impact factor: 5.443

3.  P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells.

Authors:  Byeong-Chel Lee; Tao Cheng; Gregor B Adams; Eyal C Attar; Nobuyuki Miura; Sean Bong Lee; Yoriko Saito; Ivona Olszak; David Dombkowski; Douglas P Olson; Julie Hancock; Peter S Choi; Daniel A Haber; Andrew D Luster; David T Scadden
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

Review 4.  Isolation and characterization of functional mammary gland stem cells.

Authors:  Bryan Welm; Fariba Behbod; Margaret A Goodell; J M Rosen
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

5.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

Review 6.  Cord blood in regenerative medicine: do we need immune suppression?

Authors:  Neil H Riordan; Kyle Chan; Annette M Marleau; Thomas E Ichim
Journal:  J Transl Med       Date:  2007-01-30       Impact factor: 5.531

7.  Preeclampsia in pregnancy affecting the stemness and differentiation potency of haematopoietic stem cell of the umbilical cord blood.

Authors:  Fazlina Nordin; Mohd Razif Mohd Idris; Zaleha Abdullah Mahdy; S Fadilah Abd Wahid
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-10       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.